◆ Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine2026-08-01
Author Response: Sulbactam-Durlobactam for Carbapenem-resistant Acinetobacter baumannii in India: Does Local Molecular Epidemiology Support Current Guideline Recommendations? and Antibiotic Choice for Carbapenem-resistant Pseudomonas aeruginosa: Need to Look beyond the Forest.
Subhash K Todi
原始摘要（英文原文）· Original abstract
How to cite this article: Todi SK. Author Response: Sulbactam-Durlobactam for Carbapenem-resistant Acinetobacter baumannii in India: Does Local Molecular Epidemiology Support Current Guideline Recommendations? and Antibiotic Choice for Carbapenem-resistant Pseudomonas aeruginosa: Need to Look beyond the Forest. Indian J Crit Care Med 2026;30(8):702-703.
Author Response: Sulbactam-Durlobactam for Carbapenem-resistant Acinetobacter baumannii in India: Does Local Molecular Epidemiology Support Current Guideline Recommendations? and Antibiotic Choice for Carbapenem-resistant Pseudomonas aeruginosa: Need to Look beyond the Forest. — 科研速览 Science Skim